Turkish Journal of Pharmaceutical Sciences

Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres [Turk J Pharm Sci]
Turk J Pharm Sci. 2016; 13(2): 105-123 | DOI: 10.5505/tjps.2016.05706  

Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres

Bandar E Al-dhubiab
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, KSA

Acyclovir loaded nanospheres embedded mucoadhesive film have been developed as potential drug delivery system and evaluated both ex vivo and in vivo. Poly (lactic-co-glycolic acid) nanospheres were formulated and impregnated in films prepared with varying concentrations of hydroxyethyl cellulose and eudragit RS PO. The prepared formulations (F1-F4) were evaluated by ex vivo permeation studies using rabbit mucosa in order to select the optimum formulation for further studies. In vivo studies were carried out in rabbits to assess the pharmacokinetic profile of acyclovir when delivered from mucoadhesive buccal films and its control. Ex vivo studies (6 h) indicate significant difference in permeation rate of acyclovir from mucoadhesive films (F3 > F4 > F2 > F1), suggesting the release and/or permeation of acyclovir is influenced by the film composition used. SEM images showed the nanospheres were embedded uniformly in the films. In vivo data demonstrated significant absorption (Cmax ~360.93 ng/mL; P<0.0001), prolonged duration (Tmax 6 h) and greater AUC0-α (~5 folds, P<0.0001) with buccal films in comparison to oral solution (control). The results showed

Keywords: Acyclovir, buccal delivery, eudragit, ex vivo, in vivo


Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres

Bandar E Al-dhubiab
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, KSA

Acyclovir loaded nanospheres embedded mucoadhesive film have been developed as potential drug delivery system and evaluated both ex vivo and in vivo. Poly (lactic-co-glycolic acid) nanospheres were formulated and impregnated in films prepared with varying concentrations of hydroxyethyl cellulose and eudragit RS PO. The prepared formulations (F1-F4) were evaluated by ex vivo permeation studies using rabbit mucosa in order to select the optimum formulation for further studies. In vivo studies were carried out in rabbits to assess the pharmacokinetic profile of acyclovir when delivered from mucoadhesive buccal films and its control. Ex vivo studies (6 h) indicate significant difference in permeation rate of acyclovir from mucoadhesive films (F3 > F4 > F2 > F1), suggesting the release and/or permeation of acyclovir is influenced by the film composition used. SEM images showed the nanospheres were embedded uniformly in the films. In vivo data demonstrated significant absorption (Cmax ~360.93 ng/mL; P<0.0001), prolonged duration (Tmax 6 h) and greater AUC0-α (~5 folds, P<0.0001) with buccal films in comparison to oral solution (control). The results showed

Anahtar Kelimeler: Acyclovir, buccal delivery, eudragit, ex vivo, in vivo


Bandar E Al-dhubiab. Mucoadhesive buccal films embedded with antiviral drug loaded nanospheres. Turk J Pharm Sci. 2016; 13(2): 105-123

Corresponding Author: Bandar E Al-dhubiab, Saudi Arabia


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar